Esomeprazole and omeprazole may boost the serum concentrations of benzodiazepines (by way of CYP2C19 inhibition) bringing about improved adverse effects such as drowsiness, although the scientific relevance is minimal for most patients – keep an eye on the patient for adverse effects (e. If affected person can't resume their usual https://medeusresearchchem.com/shop/